Results 131 to 140 of about 2,007,940 (182)

Values and preferences of female sex workers in Zimbabwe for long-acting injectable pre-exposure prophylaxis and the dapivirine vaginal ring: results of a mixed-methods research study. [PDF]

BMJ Glob Health
Machingura F, d'Elbée M, Kujeke T, Maguma J, Rodolph M, Baggaley R, Chabata ST, Cowan FM.   +7 more
europepmc   +1 more source

Association of human papillomavirus on risk of HIV acquisition in African women: analyses from MTN-020/ASPIRE. [PDF]

J Natl Cancer Inst
Hathaway CL, Brown ER, Cherne S, Sepulveda AL, Chirenje ZM, Jeenarain N, Naidoo L, Siva S, Singh N, Woeber K, Gaffoor Z, Mirembe BG, Kiweewa FM, Mansoor LE, Chinula L, Dadabhai S, Mugo NR, Palanee-Phillips T, Barnabas RV.   +18 more
europepmc   +1 more source

Expanding access to a choice-based multi-method PrEP market for HIV prevention. [PDF]

J Int AIDS Soc
Naidoo NP, Ayieko J, Fonner VA.
europepmc   +1 more source

Counterfactual Groups to Assess Vaccine or Treatment Efficacy in HIV Prevention Trials in High-Risk Populations in Uganda. [PDF]

Vaccines (Basel)
Abaasa A, Mayanja Y, Anywaine Z, Kusemererwa S, Ruzagira E, Kaleebu P.   +5 more
europepmc   +1 more source

Southern African HIV Clinicians Society guideline on pre-exposure prophylaxis to prevent HIV. [PDF]

South Afr J HIV Med
Macdonald P, Macdonald P, Nair G, Wattrus C, Mullick S, Pleaner M, Rousseau E, Subedar H, Joseph-Davey D, Hugo J, Delany-Moretlwe S, Bekker LG.   +11 more
europepmc   +1 more source

Lenacapavir at the Spatiotemporal Limit: Tissue Pharmacokinetics, Pharmacokinetic Tail Dynamics, and the Emergence of Capsid Resistance in Long-Acting HIV Prevention. [PDF]

Clin Pharmacol
Chris-Uchendu HC, Olwit G, Atuhaire A, Matovu I, Kirumira HN, Sasiita PK, Odongo L, Mutekanga A, Nkwanga J.   +8 more
europepmc   +1 more source

Updates on HIV Pre-exposure Prophylaxis in Latin America: Available Drugs and Implementation Status. [PDF]

Infez Med
Gonzales-Gavancho C, Araoz-Salinas JM, Ramon Tapia R, Quispe-Vicuña C, Reategui-Garcia ME, Rios-Garcia W, Baltodano-Calle MJ, Belanovic-Ramirez I, Ortiz-Pardo AN, Ortiz-Saavedra B, Campos VYM, Alave J, Gonzales-Zamora JA.   +12 more
europepmc   +1 more source

Interactions between long-acting antiretrovirals and opioids: a call for clinical awareness. [PDF]

Clin Microbiol Rev
Carbajal C, Owens F, Veeragoni D, Rodriguez M, Fernandez-Lima F, Nefzi A, Buch S, El-Hage N.   +7 more
europepmc   +1 more source

Preexposure Prophylaxis (PrEP) for HIV. [PDF]

JAMA
Spinelli MA, Ngure K, Gandhi M.
europepmc   +1 more source

Highlights on HIV Prevention and Antiretroviral Therapy from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 and Expectations from CROI 2026. [PDF]

Infect Dis Clin Microbiol
İnan A, Sayın-Kutlu S, Sönmezer MÇ, Gökengin D.   +3 more
europepmc   +1 more source